Shanghai Pharmaceuticals Holding Co., Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPMY research report →
Price Chart
About the company
Shanghai Pharmaceuticals Holding Co. , Ltd. operates as an investment holding enterprise deeply embedded in China's pharmaceutical and healthcare industries.
- CEO
- Qiuhua Yang
- IPO
- 2014
- Employees
- 49,608
- HQ
- Shanghai, SH, CN
Get TickerSpark's AI analysis on SHPMY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.25B
- P/E
- 12.93
- PEG
- -0.62
- P/S
- 0.21
- P/B
- 0.79
- EV/EBITDA
- 7.52
- Div Yield
- 3.42%
- Gross Margin
- 10.79%
- Op Margin
- 2.78%
- Net Margin
- 1.65%
- ROE
- 6.21%
- ROIC
- 3.64%
Latest fiscal year · YoY change
- Revenue
- $283.58B+3.0%
- Gross Profit
- $30.42B-0.7%
- Op Income
- $9.94B
- Net Income
- $5.72B+25.7%
- EPS
- $7.70+25.2%
- OCF Growth
- +5.6%
- FCF Growth
- +11.7%
- 52W High
- $8.30
- 52W Low
- $6.41
- 50D MA
- $7.21
- 200D MA
- $7.53
- Beta
- 0.16
- RSI (14)
- 51
- Avg Volume
- 65
No earnings-call transcripts are available for SHPMY yet.
- Free Float
- 28.6%
- Shares Outstanding
- 741.67M
- Float Shares
- 211.99M
Our SHPMY coverage
Recent articles, reports, and earnings notes.
No research on SHPMY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHPMY report →